Let's Talk About Ozempic (Updated Version)

TL;DR

GLP-1 drugs like Ozempic are the first reliably effective obesity treatment in history, reducing weight by 20%+ and cutting heart attack risk by 20%.

Key Points

• 1.Obesity is a biological trap, not a willpower failure. Hyperpalatable ultra-processed foods hijack reward centers, and once overweight, dysregulated hunger hormones actively resist weight loss — just half a Snickers excess daily compounds to 10 lbs of fat per year.
• 2.GLP-1 is a natural hunger hormone that disappears in two minutes; drugs like semaglutide mimic it for up to a week. Ozempic and Mounjaro (semaglutide and tirzepatide) send a continuous fullness signal, dramatically reducing food noise and appetite without requiring willpower.
• 3.Weight loss results rival bariatric surgery. Users can lose 10% of body weight in 3 months, over 15% in 6 months, and more than 20% after a year — previously only achievable through surgery.
• 4.Health benefits extend far beyond weight loss. Semaglutide cuts stroke/heart attack risk by 20%, tirzepatide reduces diabetes development by 66%, and the drugs also improve kidney function, sleep apnea, cancer risk, and may slow Alzheimer's — some benefits even independent of weight lost.
• 5.Side effects are mostly mild but medical supervision is critical. Nausea, vomiting, and diarrhea are common but temporary; serious issues like pancreatitis affect under 5% — and rapid weight loss without resistance training and protein causes dangerous muscle loss.
• 6.Long-term use may be necessary for many, but widespread adoption could be transformative. About 25–45% regain significant weight after stopping; a modeled scenario of mass US use over time would eliminate 50% of obesity, prevent 26 million diabetes cases, and save 5.5 million lives — with patent expiry soon to collapse prices.